Viemed Healthcare (VMD) Return on Capital Employed Growth (1y) (2019 - 2026)
Viemed Healthcare (VMD) Return on Capital Employed Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.55 Bn | 176.26 Bn | 6.27 Bn | -81.00 |
| 2 | Stryker | 128.64 Bn | 125.76 Bn | 3.81 Bn | -1,390.00 |
| 3 | Medtronic | 108.92 Bn | 99.70 Bn | 6.41 Bn | 39.00 |
| 4 | Boston Scientific | 68.50 Bn | 67.05 Bn | 3.61 Bn | 141.00 |
| 5 | Edwards Lifesciences | 47.84 Bn | 44.17 Bn | 1.29 Bn | -110.00 |
| 6 | GE HealthCare Technologies | 28.25 Bn | 25.96 Bn | 1.98 Bn | -3,185.00 |
| 7 | Dexcom | 28.23 Bn | 27.11 Bn | 750.30 Mn | 658.00 |
| 8 | Smith & Nephew | 26.93 Bn | 26.35 Bn | - | - |
| 9 | Koninklijke Philips | 25.43 Bn | 22.30 Bn | 2.07 Bn | 125.00 |
| 10 | Viemed Healthcare | 459.62 Mn | 449.86 Mn | 42.83 Mn | 110.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 110.00 |
| Dec 31, 2025 | 121.00 |
| Sep 30, 2025 | 124.00 |
| Jun 30, 2025 | 262.00 |
| Mar 31, 2025 | 205.00 |
| Dec 31, 2024 | 123.00 |
| Sep 30, 2024 | 216.00 |
| Jun 30, 2024 | 263.00 |
| Mar 31, 2024 | 355.00 |
| Dec 31, 2023 | 364.00 |
| Sep 30, 2023 | 102.00 |
| Jun 30, 2023 | -153.00 |
| Mar 31, 2023 | -425.00 |
| Dec 31, 2022 | -340.00 |
| Sep 30, 2022 | -343.00 |
| Jun 30, 2022 | -332.00 |
| Mar 31, 2022 | -1,344.00 |
| Dec 31, 2021 | -1,797.00 |
| Sep 30, 2021 | -1,617.00 |
| Jun 30, 2021 | -1,881.00 |